BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23563786)

  • 1. The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.
    Jikuzono T; Kawamoto M; Yoshitake H; Kikuchi K; Akasu H; Ishikawa H; Hirokawa M; Miyauchi A; Tsuchiya S; Shimizu K; Takizawa T
    Int J Oncol; 2013 Jun; 42(6):1858-68. PubMed ID: 23563786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of long non-coding RNA H19 predicts distant metastasis in minimally invasive follicular thyroid carcinoma.
    Dai Y; Miao Y; Zhu Q; Gao M; Hao F
    Bioengineered; 2019 Dec; 10(1):383-389. PubMed ID: 31791180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis of formalin-fixed, paraffin-embedded follicular thyroid carcinoma samples from patients who developed postoperative distant metastasis.
    Jikuzono T; Ishikawa T; Hirokawa M; Sugitani I; Ishibashi O
    BMC Res Notes; 2020 May; 13(1):241. PubMed ID: 32404135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
    Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
    Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
    Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive follicular thyroid carcinomas: prognostic factors.
    Stenson G; Nilsson IL; Mu N; Larsson C; Lundgren CI; Juhlin CC; Höög A; Zedenius J
    Endocrine; 2016 Aug; 53(2):505-11. PubMed ID: 26858184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.
    Sondermann A; Andreghetto FM; Moulatlet AC; da Silva Victor E; de Castro MG; Nunes FD; Brandão LG; Severino P
    Clin Exp Metastasis; 2015 Aug; 32(6):521-30. PubMed ID: 26007293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
    Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.
    Todorović L; Stanojević B; Mandušić V; Petrović N; Živaljević V; Paunović I; Diklić A; Saenko V; Yamashita S
    Med Oncol; 2018 Jan; 35(2):17. PubMed ID: 29340905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epithelial-mesenchymal transition regulators TWIST, SLUG and SNAIL in follicular thyroid tumours may relate to widely invasive, poorly differentiated and distant metastasis.
    Wu J; Zhang Y; Cheng R; Gong W; Ding T; Zhai Q; Wang Y; Meng B; Sun B
    Histopathology; 2019 Apr; 74(5):780-791. PubMed ID: 30368884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-miR146a expression in follicular carcinomas of the thyroid.
    Roncati L; Pignatti E; Vighi E; Magnani E; Kara E; Rochira V; Carani C; Simoni M; Maiorana A
    Pathologica; 2014 Jun; 106(2):58-60. PubMed ID: 25291868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
    Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
    Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
    Thyroid; 2012 Aug; 22(8):798-804. PubMed ID: 22853727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular thyroid carcinoma: histology and prognosis.
    D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
    Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
    Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
    Yip L; Kelly L; Shuai Y; Armstrong MJ; Nikiforov YE; Carty SE; Nikiforova MN
    Ann Surg Oncol; 2011 Jul; 18(7):2035-41. PubMed ID: 21537871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.